Patient-Reported Outcomes from a 1-Year, Real-World, Head-to-Head Comparison of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine.
Andrew M BlumenfeldAtul T PatelIra M TurnerKathleen B MullinAubrey Manack AdamsJohn F RothrockPublished in: Journal of primary care & community health (2021)
NCT02191579; https://clinicaltrials.gov/ct2/show/NCT02191579.